These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
63. Antiestrogen action in the medial basal hypothalamus and pituitary of immature female rats: insights concerning relationships among estrogen, dopamine, and prolactin. Toney TW; Katzenellenbogen BS Endocrinology; 1986 Dec; 119(6):2661-9. PubMed ID: 3780547 [TBL] [Abstract][Full Text] [Related]
64. Effects of bromocriptine on pituitary organelle marker enzyme activities in lactating and postlactating rats: selective activation of lysosomal prolactin proteolytic activity. De Marco L; Mashiter K; Caughey B; Peters TJ Endocrinology; 1984 Sep; 115(3):984-9. PubMed ID: 6086293 [TBL] [Abstract][Full Text] [Related]
65. Hyperprolactinemia exerts a negative effect on the beta-endorphin content of the rat neurointermediate pituitary lobe. Lamberts SW; Uitterlinden P; Bons EG; Zuiderwijk JM; Verleun T; Oosterom R; Hackeng WH Endocrinology; 1984 Jun; 114(6):2349-53. PubMed ID: 6327244 [TBL] [Abstract][Full Text] [Related]
66. Hypothalamic corticotropin-releasing factor immunoreactivity is reduced during induction of pituitary tumors by chronic estrogen treatment. Haas DA; Borgundvaag B; Sturtridge WC; George SR Life Sci; 1987 Nov; 41(18):2101-6. PubMed ID: 3499556 [TBL] [Abstract][Full Text] [Related]
67. Pharmacologic evidence that a D2 receptor subtype mediates dopaminergic stimulation of prolactin secretion from the anterior pituitary gland. Burris TP; Stringer LC; Freeman ME Neuroendocrinology; 1991 Aug; 54(2):175-83. PubMed ID: 1685014 [TBL] [Abstract][Full Text] [Related]
68. The role of dopamine in methylene blue-mediated inhibition of estradiol benzoate-induced anterior pituitary hyperplasia in rats. Nedvídková J; Pacák K; Haluzík M; Nedvídek J; Schreiber V Neurosci Lett; 2001 May; 304(3):194-8. PubMed ID: 11343835 [TBL] [Abstract][Full Text] [Related]
69. Modulation of brain and pituitary dopamine receptors by estrogens and prolactin. Di Paolo T; Falardeau P Prog Neuropsychopharmacol Biol Psychiatry; 1985; 9(5-6):473-80. PubMed ID: 4089182 [TBL] [Abstract][Full Text] [Related]
70. Regulation and molecular characterization of dopamine D2 receptors in a prolactin-secreting 7315a anterior pituitary tumor. Lew JY; Zawadzka H; Feigenblum D; Tang D; Filer D; Benedetto P; Goldstein M Eur J Pharmacol; 1990 Jun; 188(6):329-34. PubMed ID: 1695574 [TBL] [Abstract][Full Text] [Related]
71. Changes in the function of tuberoinfundibular dopaminergic neurons after long-term estradiol treatment in Fischer 344 rats. Arita J; Kojima Y; Kimura F Neuroendocrinology; 1990 Sep; 52(3):249-55. PubMed ID: 2120607 [TBL] [Abstract][Full Text] [Related]
72. Bromocriptine inhibits growth hormone release from rat pituitary cells in primary culture. Cronin MJ; Thorner MO; Hellmann P; Rogol AD Proc Soc Exp Biol Med; 1984 Feb; 175(2):191-5. PubMed ID: 6694976 [TBL] [Abstract][Full Text] [Related]
73. Dopaminergic regulation of the estrogen-induced glandular kallikrein in the rat anterior pituitary. Powers CA; Hatala MA Neuroendocrinology; 1986; 44(4):462-9. PubMed ID: 3029615 [TBL] [Abstract][Full Text] [Related]
74. Three-dimensional imaging of hormone-secreting cells and their microvessel environment in estrogen-induced prolactinoma of the rat pituitary gland by confocal laser scanning microscopy. Itoh J; Kawai K; Serizawa A; Yamamoto Y; Ogawa K; Matsuno A; Watanabe K; Osamura RY Appl Immunohistochem Mol Morphol; 2001 Dec; 9(4):364-70. PubMed ID: 11759065 [TBL] [Abstract][Full Text] [Related]
75. Attenuation of anterior pituitary phosphoinositide phosphorylase activity by the D2 dopamine receptor. Jarvis WD; Judd AM; MacLeod RM Endocrinology; 1988 Dec; 123(6):2793-9. PubMed ID: 2904359 [TBL] [Abstract][Full Text] [Related]
76. Effect of cabergoline, a dopamine agonist, on estrogen-induced rat pituitary tumors: in vitro culture studies. Eguchi K; Kawamoto K; Uozumi T; Ito A; Arita K; Kurisu K Endocr J; 1995 Jun; 42(3):413-20. PubMed ID: 7670571 [TBL] [Abstract][Full Text] [Related]
77. Effects of bromocriptine on prolactin cellular hypertrophy, proliferation and secretory activity in diethylstilbestrol-induced pituitary tumors. Phelps CJ; Hymer WC Mol Cell Endocrinol; 1988 Aug; 58(2-3):137-48. PubMed ID: 3208992 [TBL] [Abstract][Full Text] [Related]
78. In vivo effect of cabergoline, a dopamine agonist, on estrogen-induced rat pituitary tumors. Eguchi K; Kawamoto K; Uozumi T; Ito A; Arita K; Kurisu K Endocr J; 1995 Apr; 42(2):153-61. PubMed ID: 7627259 [TBL] [Abstract][Full Text] [Related]
79. Involvement of postnatal gonads in the maturation of dopaminergic regulation of prolactin secretion in female rats. Watanobe H; Takebe K Endocrinology; 1987 Jun; 120(6):2212-9. PubMed ID: 3569131 [TBL] [Abstract][Full Text] [Related]
80. The effect of selective sst1, sst2, sst5 somatostatin receptors agonists, a somatostatin/dopamine (SST/DA) chimera and bromocriptine on the "clinically non-functioning" pituitary adenomas in vitro. Gruszka A; Kunert-Radek J; Radek A; Pisarek H; Taylor J; Dong JZ; Culler MD; Pawlikowski M Life Sci; 2006 Jan; 78(7):689-93. PubMed ID: 16115652 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]